A Study of LY3540378 in Healthy Participants

PHASE1CompletedINTERVENTIONAL

Enrollment

134

Participants

Timeline

Start Date

March 17, 2021

Primary Completion Date

May 30, 2022

Study Completion Date

May 30, 2022

Conditions

Healthy

Interventions

DRUG

LY3540378

Administered IV or SC.

DRUG

Placebo

Administered IV or SC.

DRUG

LY3540378

Administered SC.

Trial Locations (2)

Anaheim Clinical Trials, LLC, Anaheim

Lilly Centre for Clinical Pharmacology, Singapore

All Listed Sponsors

lead

Eli Lilly and Company

INDUSTRY

NCT04768855 - A Study of LY3540378 in Healthy Participants | Biotech Hunter | Biotech Hunter